However, a review of the literature on current genetic biomarkers and immunohistochemical staining reveals two commonalities between PLNTY and ependymoma: mutations in the histone gene H3F3A and positive Glial Fibrillary Acidic Protein (GFAP) staining on immunohistochemistry (IHC). The gene discussed is GFAP; the disease is ependymoma.